ImmunityBio, Inc.IBRXNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-197.34%
↑ 100% vs avg
Percentile
P100
Near historical high
Streak
3 yr
Consecutive growthExpanding
Average
-107958.15%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | -197.34% | +89.0% |
| 2024 | -1793.37% | +97.7% |
| 2023 | -76955.47% | +47.5% |
| 2022 | -146617.08% | -326.9% |
| 2021 | -34341.76% | -1.7% |
| 2020 | -33755.37% | +74.5% |
| 2019 | -132220.93% | +28.4% |
| 2018 | -184555.32% | +8.5% |
| 2017 | -201626.67% | +24.6% |
| 2016 | -267518.18% | - |